Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $71,689.71 +4.43%
Ethereum $2,239.83 +6.43%
BNB $615.81 +3.04%
Optimism $0.12 +9.95%
Arbitrum $0.10 +9.96%
Solana $84.57 +6.34%
Polygon $0.22 +2.77%
Cosmos $1.80 +6.41%
Avalanche $9.46 +10.43%

Bitcoin $71,689.71 +4.43%
Ethereum $2,239.83 +6.43%
BNB $615.81 +3.04%
Optimism $0.12 +9.95%
Arbitrum $0.10 +9.96%
Solana $84.57 +6.34%
Polygon $0.22 +2.77%
Cosmos $1.80 +6.41%
Avalanche $9.46 +10.43%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed